Although the precise pathogenesis of PBC remains unclear, it has been postulated that B cells are involved in the ongoing inflammatory process, as B cell depletion with rituximab significantly reduced the number of AMA-producing B cells, AMA titers, and Alk-p levels (25). The gene discussed is ALK; the disease is primary biliary cholangitis.